US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 88.840
  • -0.190-0.21%
Close Nov 1 16:00 ET
  • 88.840
  • 0.0000.00%
Post 20:01 ET
4.26BMarket Cap-13501P/E (TTM)

Axsome Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Axsome Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
98.07M
+69.69%
EPS
-1.41
-6.86%
Analyst Rating
Strong Buy

Nov 3, 2024

Axsome Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 112.899M--
Nov 12, 20242024/Q3-- / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 112.899M--
Nov 12, 20242024/Q3-- / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--

Unlock Free Earnings Estimates

Axsome Therapeutics Earnings Reports

  • Axsome Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:33 ET

  • Axsome Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 17:25 ET

  • Axsome Therapeutics | 10-K: FY2023 Annual Report

    Feb 23 08:14 ET

  • Axsome Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 16:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data